High prevalence of thrombotic events in severely ill COVID-19 patients have been reported.
Pulmonary embolism as well as microembolization of vital organs may in these individuals …

Objectives: The rate of thromboembolic events among patients with coronavirus disease
2019 is high; however, there is no robust method to identify those at greatest risk. We …

Abnormal coagulation parameters are often observed in patients with coronavirus disease
2019 (COVID-19) and the severity of derangement has been associated with a poor …

Identifying a hypercoagulable state in patients with COVID-19 may help identify those at risk
for virus–induced thromboembolic events and improve clinical outcomes using personalized …

Coagulation abnormalities are common in patients with COVID-19 and associated with high
morbidity and mortality. It became a daily challenge to navigate through these abnormal …

Background Severe thromboembolic events are one of the major complications associated
with COVID-19 infection, especially among critically ill patients. We analysed ROTEM …

Background COVID‐19 associated coagulopathy (CAC) can either be localized or systemic
hypercoagulable state with increased risk of thromboembolism. This study looked into the …

Background: Patients with coronavirus disease 2019 (COVID-19) occasionally develop
respiratory failure and coagulopathy. We aimed to determine whether coagulation …

High rates of thrombosis are present in patients with severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2). Deeper insight into the prothrombotic state is essential to …

Background. COVID-19 is an ongoing global pandemic. Since the detection of the first cases
of coronavirus disease 2019 (COVID-19) in Wuhan, China, the current pandemic has …